Olema Pharmaceuticals Inc. logo

Olema Pharmaceuticals Inc.

OLMA | NASDAQ
Chart Builder DCF Calculator
$9.64
-$0.18 (-1.83%)
At close: Sep 21, 2026, 4:00 PM ET
$9.81
+$0.17 (+1.76%)
Pre-market: Sep 22, 2026, 5:49 AM ET

Market Data

Market Cap
$857.75M
Enterprise Value
$381.44M
Beta
1.99
Average Volume
1.28M
Shares Outstanding (Diluted)
104.45M
Shares Change YoY
22.17%
Institutional Ownership
98.71%
Exchange
NASDAQ
ISIN
US68062P1066

Price Performance

Price Change 1M
-8.9%
Price Change 3M
-8.4%
Price Change 6M
-32.0%
Price Change YTD
-61.9%
Price Change 1Y
15.7%
Price Change 3Y
-22.8%
Price Change 5Y
-66.1%
1M CAGR (ann.)
-16.8%
1Y CAGR (ann.)
26.7%
5Y CAGR (ann.)
-19.6%
All-Time CAGR
-24.1%

Valuation

PE Ratio
-4.53
Forward PE
N/A
PEG Ratio
0.90
Forward PEG
-0.41
PS Ratio
N/A
Forward PS
102.80
PB Ratio
1.96
P/FCF Ratio
-5.11
P/Adj. FCF Ratio
-4.52
P/OCF Ratio
-6.10
EV/Sales
N/A
EV/EBIT
-1.86
EV/EBITDA
-1.87
EV/FCF
-2.32
Earnings Yield
-22.1%
FCF Yield
-19.6%
Adj. FCF Yield
-22.1%

Financial Health

Net Cash
$460.41M
Total Debt
$660K
Cash & Short-Term Investments
$461.07M
Total Assets
$486.58M
Current Ratio
8.86
Quick Ratio
8.86
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
-249.60
Interest Coverage
0.00
Altman Z-Score
6.77
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-13.0%

Returns

Return on Assets
-42.0%
Return on Equity
-48.2%
Return on Invested Capital
-50.9%
Return on Capital Employed
-51.0%
Return on Tangible Assets
-42.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-1.4%
EPS CAGR 5Y
3.6%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-28.2%
FCF CAGR 5Y
-20.7%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
8.0%
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.60
EPS Growth Est (next Q)
22.4%
Revenue Est (next Q)
$1.25M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$28.33
Price Target Upside
193.9%

Cash Flow

Operating Cash Flow
$-164.74M
Free Cash Flow
$-164.74M
Adj. Free Cash Flow
$-186.16M
FCF Per Share
-$1.58
OCF Per Share
-$1.58
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-306K
Operating Income
$-221.13M
EBITDA
$-204M
Net Income
$-204.57M
EPS (Diluted)
-$2.13
Revenue / Employee
N/A
Profit / Employee
$-1.36M
Employees
150

© 2026 bestshares.com. All rights reserved.